Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Westerhoff Formula Cream vs Hydroquinone for Facial Melasma
NCT07508098Phase 4Completed
- Sponsor
- Pak Emirates Military Hospital
- Start
- Jul 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Westerhoff formula cream in melasma (2 arms), sponsored by Pak Emirates Military Hospital. Primary endpoint: Proportion of participants achieving 60% reduction in the Melasma Area Severity Index at 8 weeks. Started Jul 2025; status: completed.
02
Drugs
Westerhoff formula cream
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07508098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07508098.